Bio-Rad Laboratories Inc.
BIO | NYSE
$364.98
-$7.20 (-1.93%)
Nov 2, 2026, 2:08 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 10.87 | -5.03 | -14.80 | -3.45 | 5.30 | 4.56 |
PEG Ratio | -0.08 | -0.03 | 0.18 | 0.02 | 0.46 | 0.04 |
PS Ratio | 3.20 | 3.61 | 3.53 | 4.47 | 7.71 | 6.82 |
PB Ratio | 1.11 | 1.41 | 1.08 | 1.30 | 1.65 | 1.76 |
P/FCF Ratio | 22.05 | 34.82 | 43.21 | 155.99 | 42.07 | 36.42 |
P/OCF Ratio | 15.52 | 20.36 | 25.15 | 64.41 | 33.67 | 29.66 |
OCF/S Ratio | 20.60 | 17.74 | 14.04 | 6.94 | 22.91 | 22.98 |
Debt / Equity Ratio | 0.21 | 0.21 | 0.16 | 0.14 | 0.02 | 0.02 |
Quick Ratio | 4.19 | 4.85 | 4.34 | 4.29 | 2.08 | 2.40 |
Current Ratio | 5.62 | 6.48 | 5.83 | 5.55 | 2.92 | 3.39 |
Asset Turnover | 0.24 | 0.27 | 0.22 | 0.21 | 0.16 | 0.20 |
Interest Coverage | 5.52 | 5.50 | 6.83 | 12.66 | 322.59 | 19.27 |
Return on Equity | 10.20% | -28.07% | -7.29% | -37.73% | 31.09% | 38.61% |
Return on Assets | 7.18% | -19.69% | -5.18% | -26.87% | 23.90% | 29.40% |
Return on Invested Capital | 2.04% | 2.37% | 2.14% | 2.87% | 2.28% | 2.64% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 52.01% | 53.73% | 53.42% | 55.93% | 56.05% | 56.48% |
Net Profit Margin | 29.42% | -71.86% | -23.86% | -129.45% | 145.57% | 149.83% |
Pretax Profit Margin | 38.54% | -91.27% | -31.82% | -167.87% | 186.45% | 193.19% |
Operating Profit Margin | 10.47% | 10.48% | 12.65% | 17.22% | 17.12% | 16.55% |
FCF Margin | 14.50% | 10.37% | 8.17% | 2.87% | 18.33% | 18.71% |
EBITDA Margin | 48.39% | -83.46% | -24.51% | -160.19% | 191.21% | 199.50% |
Add to Watchlist
Select watchlists to add or remove BIO